Dataset opportunity
Originltd — 监管记录数据集机会
Originltd 持有的中等规模监管记录数据集，可用于监管 RAG 和合规助手。
Score
72.6
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
63%
Action
收购
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球监管事务中的人工智能市场 = 2024 年为 13.1 亿美元，复合年增长率为 18.60%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
监管记录数据集
Modality
文本
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — 许可权待明确
Buyer persona
监管科技与合规人工智能供应商
Originltd 持有一个全面的监管记录数据集，数据模态为文本，来源于业务记录、工业数据以及与制药生产相关的知识库。其结构化内容涵盖了监管申报和合规证据，非常适合训练和微调监管 RAG 系统，从而能够对复杂的合规查询提供精确、上下文感知的响应。
此类数据的价值体现在全球监管事务中的人工智能市场，该市场在 2024 年的估值为13.1 亿美元，预计将以 18.60% 的复合年增长率增长。[8] 虽然访问需要处理与制药客户的联合开发权并遵守ISO 15378 等高度监管的标准，但该数据集的稀有性和直接适用性为在这个快速扩张、高风险市场中开发先进的人工智能解决方案提供了显著的竞争优势。[8] ⚠ 尽职调查（有价值的数据，可协商的访问权限）：数据与高度监管的制药生产标准（ISO 15378）相关联；设计数据的所有权可能涉及与制药客户的联合开发权；供应链数据涉及国际分销合作伙伴。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
证据证实 Originltd 持有一个专有数据集，详细记录了数十年来专业医疗保健物流和包装的监管合规情况。这包括全球市场上儿童安全和防篡改认证的独特记录，是监管科技和合规人工智能供应商的关键资产。在一个快速增长的 13.1 亿美元市场中，这些数据直接为开发复杂的监管 RAG 模型提供了动力，使它们能够高保真地回答有关药品和管制药品包装的复杂问题。
See dimension details ↓- Dataset Specificity90
主导的“监管”，医疗保健行业，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume64
5 条证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于监管 RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
人工智能买家需求受高增长（18.60% 复合年增长率）的监管事务人工智能市场驱动，在该市场中，专业数据对于开发先进的合规和自动化解决方案至关重要。[8]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
受限/未知
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength86
5 种证据类型，5 条命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
所有权=公司所有，许可=权利不明确
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 个数据需求信号（0 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Origin Pharma Packaging 是一家家族拥有的英国中小型企业，生产和供应药品包装，预计 2026 年营业额为 3000 万英镑，并持有有价值的、休眠的运营数据作为其核心业务的副产品。[13] 问题：提供的描述“监管记录数据集”未能反映公司的实际业务，即实物产品制造和供应链。
- Deep Qualification80
✓ 通过 — Originltd 是一家药品包装的制造商和供应商，使其成为运营副产品的持有者。声称的“监管记录数据集”是可信的，因为该公司必须为其高度监管的产品维护广泛的合规、质量和设计文件（ISO 15378、FDA/欧盟法规）。[1, 10, 11, 12] 然而，由于与制药客户的联合开发活动，数据所有权可能混合，并且在无法访问具体客户合同的情况下，许可权不明确。[7, 19]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Knowledge base / docs
这是一个关于全球物流运营流程的知识库，对于需要理解供应链中监管合规实际步骤的人工智能模型很有价值。
Industrial data
这是来自制造环境的时间序列数据，提供了遵守ISO 标准的可审计证明，这对于验证产品质量和安全声明至关重要。
business_records
这些是历史业务记录，记录了一个长期、专业的分销网络，提供了处理管制药品等高度监管商品物流挑战的深入背景。
Image collection
这是一系列专业包装的设计资产和模型，提供了补充产品安全文本监管要求的视觉和结构数据。
Regulatory records
这是核心资产：一个基于文本的专有包装认证记录数据集，提供了训练人工智能导航复杂、多市场合规规则所必需的地面实况数据。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Originltd Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in Regulatory Affairs market = $1.31B in 2024, CAGR 18.60% (source: Grand View Research). [8]. Investment score 72.6/100 (confidence 0.63). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Wfl — 监管记录数据集机会
View opportunity →工业Trophyfoods — 监管记录数据集机会
View opportunity →金融Mtfx — 监管记录数据集机会
View opportunity →